Introduction
Creutzfeldt-Jakob disease (CJD), Gerstmann-Str/iussler syndrome and kuru in man, and scrapie in animals are neurodegenerative diseases transmissible to laboratory animals (Chandler, 1961; Gajdusek et al., 1966; Gibbs et al., 1968) . These diseases show characteristic pathological changes in the central nervous system, including vacuolation of neurons, astrogliosis and the development of amyloid plaques (Zlotnik & Rennie, 1965; Marsh & Kimberlin, 1975; Bendheim et al., 1984) . The amyloid fibrils accumulated in the involved brain tissue consist of an aggregated, partly protease-resistant form of prion protein, PrP cad in CJD and PrP sc in scrapie (Prusiner et al., 1983) . PrP cJD (PrP s°) is derived from cellular PrP, PrP °, by a post-translational process (Chesebro et al., 1985; Oesch et al., 1985) . Several lines of evidence have implicated PrP cJD (PrP s°) in transmission as well as pathogenesis of the diseases (Prusiner, 1982 (Prusiner, , 1991 Kitamoto et al., 1989; Hsiao et al., 1990; Prusiner & DeArmond, 1990; Prusiner et al., 1990) . Infectivity and PrP sc always copurify from the brain tissue of scrapieinfected hamsters in different purification procedures (Prusiner et al., 1983; Takahashi et al., 1986) . Furthermore, the susceptibility of a host to scrapie is influenced by the nature of its allele of a single-copy gene encoding PrP (Prusiner et al., 1990) . It has been proposed that PrP cJD (prpSc), once introduced into normal cells, converts cellular PrW into its protease-resistant form by an unknown mechanism (Prusiner & DeArmond, 1990; Prusiner, 1991; Weissmann, 1991a) . However, Czub et al. (1986, 1988) and Rubenstein et al. (1991) previously demonstrated that the accumulation of PrP sc occurred well after the increase in infectivity in the tissues of scrapie agent-inoculated animals. Furthermore, Xi et al. (1992) recently described a more obvious dissociation between infectivity and PrP sc accumulation in the brains of mice treated with amphotericin B. These findings oppose the identity of PrP sc as the infectious agent. The presence of an undetected, putative nucleic acid in the infectious agent has also been hypothesized. In the virino hypothesis, the infectious agent consists of a nucleic acid genome and a coat protein, PrP (Dickinson & Outram, 1988) . Weissmann (1991b) recently proposed another hypothesis, the unified theory, in which PrP s° (PrP caD) is associated with a putative nucleic acid; PrP sc itself can cause transmission of the disease, while the nucleic acid is modulating the biochemical properties of PrP s~. The nature of the infectious agent, particularly its relation to PrP, is still controversial (Manuelidis et al., 1987) .
Although the pathological features characteristic for CJD and scrapie are restricted to brain tissue (Prusiner et al., 1990) , replication of the infectious agent has been detected in other tissues such as spleen, lymph node, 0001-1740 © 1993 SGM salivary gland, intestine and skeletal muscle as well as in the brain (Chandler, 1961; Zlotnik & Rennie, 1965; Gajdusek et al., 1966; Eklund et al., 1967; Gibbs et al., 1968; Tateishi et al., 1979; Kimberlin & Walker, 1989) . Interestingly, the agent replicates in the lymphoreticular system, including spleen tissue, long before the involvement of the brain (Eklund et al., 1967; Kuroda et al., 1983) . Eklund et al. (1967) also demonstrated that the salivary gland gave a high level of infectivity much earlier than the brain of mice inoculated with the scrapie agent. In contrast to the brain, the infectivity initially detected in spleen and salivary gland persisted but did not increase thereafter. This suggested the possibility that the mode of agent replication in these tissues is distinct from that in the brain. In the present study, to elucidate the relationship between the infectious agent and PrP cJD, we examined the kinetics of infectivity together with the level of PrP cJD in various tissues, including spleen and salivary gland, of CJD agentinoculated mice.
Methods
Animals. Specific pathogen-free male ddY mice (Japan SLC) aged 4 weeks were used in all experiments on CJD agent transmission, Animal experiments were conducted in the biohazard prevention area (P3) of the Laboratory Animal Center for Biomedical Research of the authors' school and under the Guidelines for Animal Experimentation, Nagasaki University.
CJD agent. The Fukuoka 1 strain (Tateishi et al., 1979) , kindly provided by Dr J. Tateishi, was passaged twice in the brains of ddY mice. Inoculated mice were sacrificed just after the onset of CJD and brain tissues were removed. Brains of 15 CJD mice were pooled and homogenized in PBS. The homogenate, adjusted to 20 % (w/w) with PBS, was used as the CJD agent in the following experiments.
Determination of LD~o of the CJD agent. The CJD agent was serially diluted 10-fold with PBS, ranging from 100 to 10 9, and 0-02 ml per head of each dilution was inoculated intracerebrally into five or six mice. The inoculated mice were observed until 364 days after inoculation and the LD~0 was determined according to BehrensKfirber's formula (K~irber, 1931) .
Determination of the onset of CJD. The CJD agent-inoculated mice were observed every day and their body weights were measured every week. The onset of disease was determined by the appearance of more than five of the following t?atures: weight loss, priapism, greasy yellowish hair, ruffled body hair, upright tail, curved vertebrae, crossing legs and flaccid paralysis of legs.
Infeetivities of various tissues of CJD agent-inoculated mice. Eighty ddY mice were inoculated intracerebrally with an amount of the CJD agent equivalent to t0 a~ LD~t ~ units per head. Ten mice were sacrificed every 2 weeks until 14 weeks after inoculation. After being perfused completely with PBS, brain, salivary gland, spleen, liver and kidney tissues were removed and immediately stored at -80 °C until use. The infectivity of each tissue was determined by inoculating 0.02 ml of 20 % (w/w) homogenate of the pooled tissues into four to six mice. The inoculated mice were observed until 720 days after inoculation and the incubation period was determined as described above. The diagnosis of CJD was confirmed by pathological changes in the brains of all dead or sacrificed mice. The titre of infectivity was calculated from the mean value of incubation periods on the basis of a standard curve between titre and incubation period.
Purification of PrP cJD. Frozen tissues used for infectivity titration were homogenized in 10 raM-sodium phosphate buffer pH 7-4, containing 10% sarcosyl. The homogenate was incubated with t50 gg/ml of DNase I at 37 °C for 60 rain and centrifuged at 22000 g for 30 rain. The supernatant was centrifuged again at 215000g for 120 min. The resulting pellet was sonicated in 1% sarcosyI buffer (10 raM-sodium phosphate pH 7"4, 1% sarcosyl and 10% NaC1) and centrifuged at 305000 g for 60 min. The pellet was treated with 25 gg/ml ofproteinase K at 37 °C for 60 rain and centrifuged at 15000g for 15 min. The final pellet was used as a purified fraction of PrP cJD.
Immunoblotting. The purified PrP cJD was separated by SDS-PAGE under reduced conditions (Laemmli, 1970) and transferred electrophoretically to a nitrocellulose membrane (Towbin et aL, 1979) . The blot was blocked in PBST (PBS with 0.2 % Tween 20) containing 5 % non-fat dry milk, After washing with PBST, the blot was incubated with a rabbit antiserum raised against synthetic peptides corresponding to the amino-terminal region of hamster PrP (a kind gift of Dr M. Shinagawa) at a dilution of 1 : 2000 in PBST containing 0.2 % BSA . The resulting immune complex was visualized by autoradiography after labelling with 125I-Protein A (Amersham). The radioactivity of bound a2~I was quantified using the Bio-Image Analyzer (BAS 2000, Fuji Film) and the relative quantity of PrP c'm was estimated as the radioactivity (c.p.m.) per gram of tissue.
Results

Relationship between infectivity titre and incubation period
Male ddY mice aged 4 weeks were inoculated with 0.02 ml per head of serial 10-fotd dilutions of the CJD agent. Mortalities, incubation periods and survival periods of the inoculated mice are shown in Table 1 . According to the method of Kfirber (1931) , the LDs0 of the agent was calculated as 107.9 per gram of tissue. Fig. 1 shows the correlation between the incubation period and the dilution of the agent. A linear relationship was obtained in the range of incubation periods between 108.5 and 192.5 days. Since the LDs0 of the agent used was 1079/g, the relationship between the infectivity titre and the incubation period is given by loglo(LD~0/g ) = 13-067-0.0476y, 108.5 < y < 192.5. In this formula, y represents the incubation period, in days.
Infectivities in various, tissues of CJD agent-inoculated mice
Mice were inoculated with the CJD agent, 10 s5 LDso units per head, intracerebrally. Pathological changes in the brain tissue and clinical signs of CJD became obvious approximately 7 and 14 weeks after inoculation, respectively. The inoculated mice were sacrificed 6 h (0 week) post-inoculation (p.i.) and then every 2 weeks until 14 weeks, and brain, salivary gland, spleen, liver and kidney tissues were removed. Infectivity of each -8 0/6 -9 0/6 * Male ddY mice aged 4 weeks were inoculated with 0.02 ml of each dilution and observed every day until 364 days p.i, Onset of disease was determined as described in the text. tissue was examined by inoculating the tissue homogenate into four to six mice. The titre of infectivity was calculated from the mean incubation period of the inoculated mice according to the formula described above. As shown in Table 2 , infectivity was detected in all the tissues examined 6 h p.i. (indicated as week 0 in the table). The infectivities of liver and kidney declined to undetectable levels by 2 weeks and were barely detected thereafter. In brain, the titre of infectivity declined a little, from 10 55° to 10 4'~9 LD~o/g , during the first 4 weeks, and the logarithmic increase in titre occurred 6 weeks p.i., reaching a level of more than 10 TM LDso/g at 14 weeks. Although infectivities of salivary gland and spleen also continued to be readily detectable until 14 weeks, kinetics of the titre in these tissues appeared to be distinct from those in the brain. The titre of the salivary glands rose nearly 100-fold, from 10 ~31 to 10 ~21 LDs0/g, during the first 2 weeks and the maximum titre, 10631 LDs0/g, was reached by 4 weeks. This level of titre was maintained until 8 weeks, then declined gradually reaching the lowest, 1049a LD~0/g, by 14 weeks. The spleen tissue also showed a rapid increase in infectivity soon after inoculation of the agent, reaching a titre of 10 °'~5 LD~0/g by 8 weeks, and then fluctuating between 105.59 and 1065~ LDso/g. 
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Accumulation of PrP cad in the tissues
The PrP cad in some of the tissue homogenates used in the infectivity assay was purified and detected using immunoblotting. Purified fractions of PrP cad were treated with proteinase K before immunoblotting to distinguish the normal cellular isoform, PrP °. Fig. 2(c) shows results only up to 14 weeks, but PrP cJD was detectable neither in kidney nor in liver throughout the course of the experiments. Although P r P cad w a s not detected during the early time-course, it became detectable in brain, salivary gland and spleen 6, 4 and 6 weeks p.i., respectively (Fig. 2 a to c) . Maximal levels were reached by 14 weeks in all tissues, and rates of accumulation appeared to be similar. Three species of PrP c' TD comigrating with 26K, 22K and 19K markers, respectively, were detected in brain and salivary gland. In spleen, an additional fast-migrating band corresponding to 17K was observed.
Comparison of kinetics of infectivity titre and PrP cad accumulation
Kinetics of PrP cad accumulation in brain, salivary gland and spleen were analysed quantitatively and compared with those of infectivity (Fig. 3) . The radioactivity of 125I-Protein A bound to PrP cJD on the immunoblots shown in Fig. 2 was determined and relative quantities of PrP cJD were expressed as radioactivities (c.p.m.) per gram of the tissue. A linear relationship of the radioactivity with the quantity of PrP cad was obtained in the range from 1 to 500 mg of the 14 week brain tissue (data not shown). In brain, both time-course and rate of PrP c'JD accumulation were fairly well correlated with those of increase in infectivity (Fig. 3 a) . On the other hand, as shown in Fig. 3 (b, c) , an obvious discrepancy between PrP cJD and infectivity was observed in the salivary gland, in particular, and spleen. During the early time after inoculation of the agent, both tissues showed high titres of infectivity in the order of l0 G LDs0/g , although PrP caD was not yet detectable. Furthermore, between 8 and 14 weeks, the kinetics of infectivity and PrP cad accumulation in salivary gland reversed. As a consequence, salivary gland at 14 weeks showed the highest level of PrP cad accumulation despite its having the lowest value for the titre of infectivity.
Discussion
In the present study, we analysed kinetics of infectivity in various tissues of CJD agent-inoculated mice as compared with PrP CJD accumulation in tissues. Replication of the infectious agent first appeared in salivary gland and spleen soon after inoculation. In brain, the increase in infectivity was delayed and became obvious at 6 weeks. This confirms previous findings (Eklund et al., 1967; Kuroda et al., 1983) that the primary sites of agent replication are the salivary gland and spleen rather than the brain. No significant level of infectivity was detectable in kidney and liver. Among the tissues examined, PrP cJD accumulation was detected only in those which showed replication of the agent. Furthermore, the brain revealed a good correlation between infectivity and PrP cJD accumulation. These together indicate close association of PrP cJD with the infectious agent.
On the other hand, the high titres of infectivity in salivary gland and spleen early after inoculation were distinguishable from PrP cJD. Rubenstein et al. (1991) similarly showed that infectivity reached a maximum level in the spleen of scrapie agent-inoculated animals well before PrP cJD became detectable. Dissociation of infectivity from PrP se in the brain was also recently demonstrated by use of mice treated with amphotericin B. Both the clinical symptoms and the PrP se accumulation in scrapie-infected mice were retarded, and replication of the infectious agent was unaffected (Xi et al., 1992) . This dissociation may indicate that PrP cJD (PrP s°) is not essential for replication of the infectious agent, although the possibility remains that an extremely small, undetectable amount of the protein is sufficient to reveal infectivity. Recently, Btieler et al. (1992) reported the development of mice lacking a functional PrP gene. Surprisingly, the development and behaviour of these PrP-negative mice were normal. Thus, testing the susceptibility of the PrP-negative mice to scrapie or CJD agents may clarify whether PrP is an essential component of the infectious agent. The most important finding of the present study is that the kinetics of infectivity are reversed from the PrP cad accumulation in the salivary gland during the late post-inoculation time-course; that is, infectivity declined as PrP cJD accumulated in this tissue. This strongly suggests that PrP cJD is not itself the infectious agent, if the former is an essential component of the latter. No correlation between the kinetics of these factors in the spleen supports this idea.
Inaccuracy of a quantitative bioassay of the infectious agent may make interpretation of the results difficult in this kind of study. Recently, Race & Ernst (1992) described the lack of a quantitative correlation between PrP s° and infectivity in the spleen of scrapie-infected mice, but they interpreted the discrepancy to be due to inaccuracy of the infectivity assay, an endpoint titration. They investigated the infectivity titration error by determining the infectivity titres of eight different but equivalent spleen homogenates, and discovered that there appeared to be a 10-to 15-fold difference in comparable samples. It is important to note that the infectious agent can easily aggregate with cellular elements and itself. If aggregation occurs in a serial dilution, an endpoint titration assay may produce a falsely low infectivity titre. In the present study, we measured infectivity by the incubation period method formalized by Prusiner et aI. (1980) , in which undiluted samples are used, thus minimizing the possibility of aggregation. Indeed, as shown in Table 2 , differences in incubation periods of four to six comparable samples appeared to be less than 10%. Bessen & Marsh (1992) observed differences in properties of sedimentation in sarcosyl and sensitivity to digestion with proteinase K between PrPs raised by two different strains of the transmissible mink encephalopathy (TME) agent. They concluded that the differences in biochemical properties were due to different posttranslational modifications of the two PrW ME. Since we quantified PrP cJD after sedimentation in sarcosyl and treatment with proteinase K, it is possible to argue that some parts of the PrP cJD molecules in salivary gland or spleen might be lost during the process of purification due to differences in post-translational modification among the tissues. Determination of the quantity of PrP cJD in unprocessed original lysates used for the infectivity assay may be needed to clarify further the relationship between PrP cJD accumulation and infectivity titre in the tissues. Meanwhile, the available information indicates that the difference in post-translational modification results in the different mobility of the protein in polyacrylamide gels. As shown in Fig. 2 , the mobilities of three PrP cJD species from salivary gland were identical to those from the brain, suggesting that the posttranslational process is similar among the tissues. An additional fast migrating band was detected in the spleen tissue. This may have been an alternatively processed protein, but the spleen shared the three authentic species of PrP caD with the other tissues. It is more likely that the additional fast migrating band reflects the high endogenous proteolytic activity of the spleen tissue.
Although kinetics of infectivity in the salivary gland and spleen were distinct from those of the brain, the time-course and rate ofPrP cJD accumulation were similar among the tissues. This indicates that the mechanism of PrP caD accumulation is not the same as that of the agent replication. It has been proposed that PrP sc (PrP csD) itself causes the conversion of PrW to its proteaseresistant form, PrP sc (prpCJD), although the nature of the conversion is unknown. When exogenous PrP cJD is introduced into cells, the conversion may occur autonomously regardless of the cell type. On the other hand, replication of the infectious agent seems to be regulated in a tissue-specific manner. This can be explained fully by the idea that the infectious agent is not the same as PrP cJD. The possibility remains that tissue-specific, noninfectious cellular components are involved in either activation or inactivation of the specific infectivity of PrP cJD and that the specific infectivity among tissues may change over time.
Our present findings strongly suggest that PrP cad is unlikely to be the agent itself, but that PrP cad accumulation is associated with replication of the infectious agent. Further studies are needed to elucidate the nature of the infectious agent in CJD and scrapie.
